APPENDIX
DISCLOSURE FORM
FORM SAR 6
Lodge with the Stock Exchange (which may publicise) and with the Panel.A copy must also be sent to the company the voting securities of which (or the rights over the voting securities of which) are acquired.
Date of disclosure 12-11-2024
DISCLOSURE UNDER RULE 6 OF THE IRISH TAKEOVER PANEL ACT, 1997, SUBSTANTIAL ACQUISITION RULES, 2007 ("SARs")
Date of Acquisition ...11-11-2024
Acquisition in ADIENT PLC (name of company)
| (1) | Class of voting securities(e.g. ordinary shares) | Number of voting securities/rights over voting securities acquired
| If rights over voting securities acquired, as opposed to the securities themselves specify nature of rights |
|
| Ordinary Shares | 40,890 securities with voting rights |
|
| (2) | Resultant total holding of rights securities (and % of total voting securities) in issue) | Resultant total holding of voting over voting securities (and % of total voting securities in issue) | Total percentage |
|
| 15,701,162 (18.00%) |
| 15,701,162 (18.00%) |
|
| | ||
(3) Party making disclosure: BlackRock, Inc.
(4) (a) Name of person acquiring securities or rights over securities: BlackRock, Inc.
and if different, beneficial owner
(b) Names of any other persons acting in concert (see SAR 3)
Signed, for and on behalf of the party named in (3) above
(Also print name of signatory) Jana Blumenstein
Telephone and extension number: +44 0207 743 3650
Note 1. Under SAR 3, the holdings of and acquisitions by persons acting in concert must be aggregated and treated as a holding of or acquisition by one person. SAR 8(b) requires persons who must aggregate holdings to disclose certain disposals.
Note 2. "Stock Exchange": see definition in Rule 2.1(a) of Part A of the Takeover Rules.
For full details of the SARs disclosure requirements, see Rules 4, 6 and 8(b) of the SARs. If in doubt, consult the Panel.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
